Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Vermeiren, Yannick"" wg kryterium: Autor


Tytuł :
Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
Autorzy :
Mussele, Stefan
Bekelaar, Kim
Le Bastard, Nathalie
Vermeiren, Yannick
Saerens, Jos
Somers, Nore
Mariën, Peter
Goeman, Johan
De Deyn, Peter P.
Engelborghs, Sebastiaan
Pokaż więcej
Temat :
MILD cognitive impairment
ALZHEIMER'S disease research
DEPRESSION in old age
FRONTAL lobe diseases
NEUROBEHAVIORAL disorders
PATIENTS
Źródło :
International Journal of Geriatric Psychiatry; Sep2013, Vol. 28 Issue 9, p947-958, 12p, 1 Diagram, 1 Chart, 3 Graphs
Czasopismo naukowe
Tytuł :
Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults.
Autorzy :
Mussele, Stefan
Le Bastard, Nathalie
Vermeiren, Yannick
Saerens, Jos
Somers, Nore
Mariën, Peter
Goeman, Johan
De Deyn, Peter P.
Engelborghs, Sebastiaan
Pokaż więcej
Temat :
MILD cognitive impairment
SYMPTOMS
ALZHEIMER'S patients
PATIENTS
Źródło :
International Journal of Geriatric Psychiatry; Mar2013, Vol. 28 Issue 3, p265-275, 11p, 4 Charts, 1 Graph
Czasopismo naukowe
Tytuł :
Author Correction: A complete pupillometry toolbox for real-time monitoring of locus coeruleus activity in rodents.
Autorzy :
Privitera M; Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Ferrari KD; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.; Experimental Imaging and Neuroenergetics, Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
von Ziegler LM; Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Sturman O; Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Duss SN; Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Floriou-Servou A; Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Germain PL; Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Vermeiren Y; Department of Biomedical Sciences, Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Antwerpen, Belgium.; Department of Neurology and Alzheimer Center, University of Groningen and University Medical Center Groningen (UMCG), Groningen, the Netherlands.
Wyss MT; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.; Experimental Imaging and Neuroenergetics, Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
De Deyn PP; Department of Biomedical Sciences, Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Antwerpen, Belgium.; Department of Neurology and Alzheimer Center, University of Groningen and University Medical Center Groningen (UMCG), Groningen, the Netherlands.; Department of Neurology, Memory Clinic of Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium.
Weber B; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland. .; Experimental Imaging and Neuroenergetics, Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. .
Bohacek J; Laboratory of Molecular and Behavioral Neuroscience, Institute for Neuroscience, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. .; Neuroscience Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland. .
Pokaż więcej
Źródło :
Nature protocols [Nat Protoc] 2021 Jan 14. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Published Erratum
Tytuł :
[The behavioral and psychological symptoms of dementia in down syndrome (BPSD-DS) scale: comprehensive assessment of psychopathology in down syndrome].
Autorzy :
Dekker AD; Afdeling Neurologie en Alzheimer Onderzoekscentrum, Universitair Medisch Centrum Groningen, Rijksuniversiteit Groningen, postbus 30.001, 9700 RB, Groningen, Nederland.; Instituut Born-Bunge, Universiteit Antwerpen, Wilrijk, België.
Vermeiren Y; Afdeling Neurologie en Alzheimer Onderzoekscentrum, Universitair Medisch Centrum Groningen, Rijksuniversiteit Groningen, postbus 30.001, 9700 RB, Groningen, Nederland.; Instituut Born-Bunge, Universiteit Antwerpen, Wilrijk, België.
Beugelsdijk G; Ipse de Bruggen, Nieuwveen/Zwammerdam, Nederland.
Schippers M; Ipse de Bruggen, Nieuwveen/Zwammerdam, Nederland.
Hassefras L; Ipse de Bruggen, Nieuwveen/Zwammerdam, Nederland.
Eleveld J; Cosis, Groningen, Nederland.
Grefelman S; Cosis, Groningen, Nederland.
Fopma R; Talant, Heerenveen, Nederland.
Bomer-Veenboer M; Pameijer, Rotterdam, Nederland.
Oosterling GDE; Aveleijn, Borne, Nederland.
Scholten E; Elver, Nieuw-Wehl, Nederland.
Tollenaere M; Instituut Born-Bunge, Universiteit Antwerpen, Wilrijk, België.; Afdeling Neurologie, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim en Hoge Beuken, Antwerpen, België.
Van Goethem G; Het GielsBos, Gierle, België.; Afdeling Neurologie, Universitair Ziekenhuis Antwerpen, Edegem, België.
Zu Eulenburg C; Afdeling Epidemiologie, Universitair Medisch Centrum Groningen, Rijksuniversiteit Groningen, Groningen, Nederland.
Coppus AMW; Dichterbij, Gennep, Nederland.; Afdeling Eerstelijnsgeneeskunde, Radboud Universitair Medisch Centrum, Nijmegen, Nederland.
De Deyn PP; Afdeling Neurologie en Alzheimer Onderzoekscentrum, Universitair Medisch Centrum Groningen, Rijksuniversiteit Groningen, postbus 30.001, 9700 RB, Groningen, Nederland. .; Instituut Born-Bunge, Universiteit Antwerpen, Wilrijk, België. .; Afdeling Neurologie, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim en Hoge Beuken, Antwerpen, België. .
Pokaż więcej
Transliterated Title :
De BPSD-DS evaluatieschaal voor dementiegerelateerde gedragsveranderingen bij mensen met downsyndroom.
Źródło :
Tijdschrift voor gerontologie en geriatrie [Tijdschr Gerontol Geriatr] 2018 Oct; Vol. 49 (5), pp. 187-205. Date of Electronic Publication: 2018 Sep 20.
Typ publikacji :
Journal Article
MeSH Terms :
Dementia/*diagnosis
Down Syndrome/*psychology
Problem Behavior/*psychology
Aged ; Anxiety/diagnosis ; Anxiety/etiology ; Apathy ; Case-Control Studies ; Depression/diagnosis ; Depression/etiology ; Diagnosis, Differential ; Female ; Humans ; Male ; Psychopathology
Czasopismo naukowe
Tytuł :
Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease.
Autorzy :
Dekker AD; Department of Neurology and Alzheimer Research Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
Vermeiren Y; Department of Neurology and Alzheimer Research Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
Carmona-Iragui M; Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
Benejam B; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
Videla L; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
Gelpi E; Neurological Tissue Bank-Biobanc, Hospital Clinic Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Aerts T; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
Van Dam D; Department of Neurology and Alzheimer Research Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
Fernández S; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
Lleó A; Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.
Videla S; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.; Faculty of Health and Life Sciences, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Sieben A; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
Martin JJ; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
Blesa R; Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.
Fortea J; Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
De Deyn PP; Department of Neurology and Alzheimer Research Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.; Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium.
Pokaż więcej
Corporate Authors :
Netherlands Brain Bank
Źródło :
Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2017 Nov 23; Vol. 10, pp. 99-111. Date of Electronic Publication: 2017 Nov 23 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
Autorzy :
Vermeiren Y; Laboratory of Neurochemistry and Behavior, Reference Center for Biological Markers of Dementia, University of Antwerp, Antwerp, Belgium.
Le Bastard N
Van Hemelrijck A
Drinkenburg WH
Engelborghs S
De Deyn PP
Pokaż więcej
Źródło :
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2013 Sep; Vol. 9 (5), pp. 488-98. Date of Electronic Publication: 2012 Nov 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amino Acids/*cerebrospinal fluid
Biogenic Amines/*cerebrospinal fluid
Dementia/*cerebrospinal fluid
Dementia/*psychology
Mental Disorders/*etiology
Neurotransmitter Agents/*cerebrospinal fluid
Aged ; Chromatography, High Pressure Liquid ; Dementia/complications ; Female ; Humans ; Male ; Mental Disorders/cerebrospinal fluid
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies